| Product Code: ETC12463412 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Vietnam Imatinib Drug Market Overview |
3.1 Vietnam Country Macro Economic Indicators |
3.2 Vietnam Imatinib Drug Market Revenues & Volume, 2021 & 2031F |
3.3 Vietnam Imatinib Drug Market - Industry Life Cycle |
3.4 Vietnam Imatinib Drug Market - Porter's Five Forces |
3.5 Vietnam Imatinib Drug Market Revenues & Volume Share, By Drug Form, 2021 & 2031F |
3.6 Vietnam Imatinib Drug Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Vietnam Imatinib Drug Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Vietnam Imatinib Drug Market Revenues & Volume Share, By Sales Channel, 2021 & 2031F |
3.9 Vietnam Imatinib Drug Market Revenues & Volume Share, By Mode of Administration, 2021 & 2031F |
4 Vietnam Imatinib Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidence of cancer cases in Vietnam |
4.2.2 Growing awareness about the effectiveness of imatinib in treating certain types of cancer |
4.2.3 Rising healthcare expenditure and improving access to advanced medical treatments in the country |
4.3 Market Restraints |
4.3.1 High cost of imatinib treatment leading to affordability issues for some patients |
4.3.2 Limited availability of specialized healthcare facilities offering imatinib therapy in remote areas |
5 Vietnam Imatinib Drug Market Trends |
6 Vietnam Imatinib Drug Market, By Types |
6.1 Vietnam Imatinib Drug Market, By Drug Form |
6.1.1 Overview and Analysis |
6.1.2 Vietnam Imatinib Drug Market Revenues & Volume, By Drug Form, 2021 - 2031F |
6.1.3 Vietnam Imatinib Drug Market Revenues & Volume, By Tablets, 2021 - 2031F |
6.1.4 Vietnam Imatinib Drug Market Revenues & Volume, By Capsules, 2021 - 2031F |
6.1.5 Vietnam Imatinib Drug Market Revenues & Volume, By Powder Form, 2021 - 2031F |
6.1.6 Vietnam Imatinib Drug Market Revenues & Volume, By Liquid Form, 2021 - 2031F |
6.1.7 Vietnam Imatinib Drug Market Revenues & Volume, By Extended Release Tablets, 2021 - 2031F |
6.2 Vietnam Imatinib Drug Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Vietnam Imatinib Drug Market Revenues & Volume, By Leukemia Treatment, 2021 - 2031F |
6.2.3 Vietnam Imatinib Drug Market Revenues & Volume, By Gastrointestinal Stromal Tumors, 2021 - 2031F |
6.2.4 Vietnam Imatinib Drug Market Revenues & Volume, By Chronic Myeloid Leukemia, 2021 - 2031F |
6.2.5 Vietnam Imatinib Drug Market Revenues & Volume, By Breast Cancer Treatment, 2021 - 2031F |
6.2.6 Vietnam Imatinib Drug Market Revenues & Volume, By Rare Tumor Management, 2021 - 2031F |
6.3 Vietnam Imatinib Drug Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Vietnam Imatinib Drug Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Vietnam Imatinib Drug Market Revenues & Volume, By Cancer Research Centers, 2021 - 2031F |
6.3.4 Vietnam Imatinib Drug Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.3.5 Vietnam Imatinib Drug Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.3.6 Vietnam Imatinib Drug Market Revenues & Volume, By Government Healthcare Units, 2021 - 2031F |
6.4 Vietnam Imatinib Drug Market, By Sales Channel |
6.4.1 Overview and Analysis |
6.4.2 Vietnam Imatinib Drug Market Revenues & Volume, By Direct Procurement, 2021 - 2031F |
6.4.3 Vietnam Imatinib Drug Market Revenues & Volume, By Distributors, 2021 - 2031F |
6.4.4 Vietnam Imatinib Drug Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
6.4.5 Vietnam Imatinib Drug Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.4.6 Vietnam Imatinib Drug Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.5 Vietnam Imatinib Drug Market, By Mode of Administration |
6.5.1 Overview and Analysis |
6.5.2 Vietnam Imatinib Drug Market Revenues & Volume, By Oral Administration, 2021 - 2031F |
6.5.3 Vietnam Imatinib Drug Market Revenues & Volume, By Injection Therapy, 2021 - 2031F |
6.5.4 Vietnam Imatinib Drug Market Revenues & Volume, By Infusion Therapy, 2021 - 2031F |
6.5.5 Vietnam Imatinib Drug Market Revenues & Volume, By Combination Therapy, 2021 - 2031F |
6.5.6 Vietnam Imatinib Drug Market Revenues & Volume, By Targeted Therapy, 2021 - 2031F |
7 Vietnam Imatinib Drug Market Import-Export Trade Statistics |
7.1 Vietnam Imatinib Drug Market Export to Major Countries |
7.2 Vietnam Imatinib Drug Market Imports from Major Countries |
8 Vietnam Imatinib Drug Market Key Performance Indicators |
8.1 Number of new cancer cases diagnosed annually in Vietnam |
8.2 Adoption rate of imatinib treatment among oncologists in the country |
8.3 Average waiting time for patients to access imatinib therapy in major healthcare centers |
9 Vietnam Imatinib Drug Market - Opportunity Assessment |
9.1 Vietnam Imatinib Drug Market Opportunity Assessment, By Drug Form, 2021 & 2031F |
9.2 Vietnam Imatinib Drug Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Vietnam Imatinib Drug Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Vietnam Imatinib Drug Market Opportunity Assessment, By Sales Channel, 2021 & 2031F |
9.5 Vietnam Imatinib Drug Market Opportunity Assessment, By Mode of Administration, 2021 & 2031F |
10 Vietnam Imatinib Drug Market - Competitive Landscape |
10.1 Vietnam Imatinib Drug Market Revenue Share, By Companies, 2024 |
10.2 Vietnam Imatinib Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here